Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates


WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the third quarter ended September 30, 2024 and provided key business updates.

Follow this link:
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Related Posts